Fig. 2
Efficacy outcomes with garsorasib monotherapy. a Best tumor response and tumor burden change from baseline. b Swimmer plot of time to response, treatment duration. c Kaplan-Meier estimates of progression-free survival
Fig. 2 | Signal Transduction and Targeted Therapy
